Hämostaseologie, Table of Contents Hamostaseologie 1989; 09(04): 204-208DOI: 10.1055/s-0038-1655271 Originalarbeiten Schattauer GmbH Hirudin als potentielles Antikoagulans zur Prävention der Rethrombosierung nach intrakoronarer Lyse und Angioplastie Authors Author Affiliations F. Markwardt 1 Institut für Pharmakologie und Toxikologie der Medizinischen Akademie Erfurt Recommend Article Abstract Buy Article(opens in new window) Full Text References LITERATUR 1 Bagdy D, Barabas E, Graf L, Peterson T E, Magnusson S. Hirudin. Meth Enzymol 1976; 45: 669-78. 2 Baskova I P, Cherkesova D U, Mosolov V V. Hirudin from leech heads and whole leeches and “pseudo-hirudin” from leech bodies. Thromb Res 1983; 30: 459-67. 3 Bichler J, Fichtl B, Siebeck M, Fritz H. Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration. Arzneimittelforschung 1988; 38: 704-10. 4 Bucha E, Nowak G, Markwardt E. Prevention of experimental coronary thrombosis by hirudin. Folia Haematol 1988; 115: 52-58. 5 Dodt J, Machleidt W, Seemüller U, Maschler R, Fritz H. Isolation and characterization of hirudin isoinhibitors and sequence analysis of hirudin PA. Biol Chem Hoppe-Seyler 1986; 367: 803-11. 6 Dodt J, Seemüller U, Maschler R, Fritz H. The complete covalent structure of hirudin. Biol Chem Hoppe-Seyler 1985; 366: 379-85. 7 Glusa E, Wolfram U. The contractile response of vascular smooth muscle to thrombin and its inhibition by thrombin inhibitors. Folia Haematol 1988; 115: 94-100. 8 Glusa E, Urban U. Studies in platelet functions in hirudin plasma. Folia Haematol 1988; 115: 88-93. 9 Hauptmann J, Brüggener E. Influence of hirudin on the consumption of antithrombin III in experimental DIC. Folia Haematol 1988; 115: 83-87. 10 Hoffmann A, Markwardt F. Inhibition of the thrombin-platelet reaction by hirudin. Haemostasis 1984; 14: 164-69. 11 Ishikawa A, Hafter R, Seemüller U, Gokel J M, Graeff H. The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC). Thromb Res 1980; 19: 351-58. 12 Kaiser B, Markwardt F. Antithrombotic and haemorrhagic effects of the naturally occurring thrombin inhibitor hirudin. Folia Haematol 1988; 115: 41-46. 13 Kaiser B, Simon A, Markwardt F. Antithrombotic effects of recombinant hirudin in experimental angioplasty and intravascular thrombolysis. Thromb Haemost. (in press). 14 Klöcking H P, Güttner J, Fink E. Toxicological studies with recombinant hirudin. Folia Haematol 1988; 115: 75-82. 15 Klöcking H P, Markwardt F. Influence of recombinant hirudin on the thrombogenicity of prothrombin complex concentrates. Pharmazie 1989; 44: 341-42. 16 Krupinski K, Breddin H K, Markwardt F, Haarmann W. Antithrombotic effects of three thrombin inhibitors in a rat model of laser-induced thrombosis. Haemostasis 1989; 19: 74-82. 17 Markwardt F. Untersuchungen über Hirudin. Naturwissenschaften 1955; 42: 537-38. 18 Markwardt F. Die antagonistische Wirkung des Hirudins gegen Thrombin in vivo. Naturwissenschaften 1956; 43: 111. 19 Markwardt F. Untersuchungen über den Mechanismus der blutgerinnungshemmenden Wirkung des Hirudins. NaunynSchmiedebergs Arch Pharmacol 1956; 229: 389-99. 20 Markwardt F. Die Isolierung und chemische Charakterisierung des Hirudins. HoppeSeyler’s Z Physiol Chem 1957; 308: 147-56. 21 Markwardt F. Versuche zur pharmakologischen Charakterisierung des Hirudins. Naunyn-Schmiedebergs Arch Pharmacol 1958; 234: 516-29. 22 Markwardt F. Hirudin as an inhibitor of thrombin. In: Meth Enzymol 19: Proteolytic Enzymes. Perlmann G E, Lorand L. (eds). New York, London: Academic Press; 1970: 924-32. 23 Markwardt F. Pharmacology of hirudin: one hundred years after the first report of the anticoagulant agent. Biomed Biochim Acta 1985; 44: 1007-13. 24 Markwardt F. Antithrombotic action of hirudin in experimental coronary thrombosis (Abstr). European Society of Cardiology “Thrombosis and Platelets”, Tours. 1986 25 Markwardt F. Pharmacological approaches to thrombin regulation. Ann NY Acad Sci 1986; 485: 204-14. 26 Markwardt F. Prevention of coronary thrombosis by hirudin. In: Cardiovascular Pharmacology ’87.. Papp J G. (ed). Budapest: Akademiai Kiado; 1987: 449-56. 27 Markwardt F. Pharmacology of recombinant hirudin (Abst 0134). Xth International Congress of Pharmacology, Sydney. 1987 28 Markwardt F. Anticoagulants after Thrombolysis. In: Reperfusion and Revascularisation in Acute Myocardial Infarction. Schettler G, Jennings R B, Rapoport E, Wenger N K, Bernhardt R. (eds). Berlin Heidelberg: Springer; 1988: 137-43. 29 Markwardt F. Biochemistry and pharmacology of hirudin. In: Hemostasis and Animal Venoms. Pirkle H, Markland Jr F S. (eds). New York, Basel: Dekker; 1988: 255-69. 30 Markwardt F. The comeback of hirudin an old-established anticoagulant agent. Folia Haematol 1988; 115: 10-23. 31 Markwardt F. Pharmacology of selective thrombin inhibitors. Nouv Rev Fr Hematol 1988; 30: 161-5. 32 Markwardt F, Bernstein K, Drawert J, Eger H, Klöcking H P, Sedlarik K, Vollmar V, Wilde J. Thrombolytische Behandlung einer experimentellen Koronarthrombose mit Streptokinase. Exp Pathol 1977; 14: 76-88. 33 Markwardt F, Fink E, Kaiser B, Klöcking H P, Nowak G, Richter M, Stürzebecher J. Pharmacological survey of recombinant hirudin. Pharmazie 1988; 43: 202-7. 34 Markwardt F, Hauptmann J, Nowak G, Kleßen C, Walsmann P. Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb Haemost 1982; 47: 226-29. 35 Markwardt F, Huan X O, Fareed J, Walenga J M, Munch M, Hoppensteadt D. Pharmacokinetics of recombinant hirudin in primates. FASEB, Las Vegas. 1988 36 Markwardt F, Kaiser B, Nowak G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res 1989; 54: 377-88. 37 Markwardt F, Klöcking H P, Sedlarik K, Drawert J. Tierexperimentelle Untersuchungen zur thrombolytischen Wirkung von Ocrase. Acta Biol Med Ger 1977; 36: 1315-27. 38 Markwardt F, Landmann H. Blutgerinnungshemmende Proteine, Peptide und Aminosäurederivate. In: Handbook of Experimental Pharmacology. Vol. 27. Markwardt F. (ed). Berlin, Heidelberg: Springer; 1976: 76-142. 39 Markwardt F, Nowak G, Hoffmann J. The influence of drugs on disseminated intravascular coagulation (DIC). II. Effects of naturally occurring and synthetic thrombin inhibitors. Thromb Res 1977; 11: 275-83. 40 Markwardt F, Nowak G, Hoffmann J. Comparative study on thrombin inhibitors in experimental microthrombosis. Thromb Haemost 1983; 49: 235-37. 41 Markwardt F, Nowak G, Stürzebecher J, Griessbach U, Walsmann P, Vogel G. Pharmacokinetics and anticoagulant effect of hirudin in man. Thromb Haemost 1984; 52: 160-63. 42 Markwardt F, Nowak G, Stürzebecher J, Vogel G. Clinico-pharmacological studies with recombinant hirudin. Thromb Res 1988; 52: 393-400. 43 Markwardt F, Nowak G, Stürzebecher J, Walsmann P. Studies on the pharmacokinetics of hirudin. Biomed Biochim Acta 1987; 46: 237-44. 44 Markwardt F, Walsmann P. Die Reaktion zwischen Hirudin und Thrombin. HoppeSeyler’s Z Physiol Chem 1958; 312: 85-98. 45 Markwardt F, Walsmann P. Reindarstellung und Analyse des Thrombininhibitors Hirudin. Hoppe-Seyler’s Z Physiol Chem 1967; 348: 1381-86. 46 Nowak G, Markwardt F. Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs. Exp Pathol 1980; 18: 438-43. 47 Nowak G, Markwardt F, Fink E. Pharmacokinetic studies with recombinant hirudin in dogs. Folia Haematol 1988; 115: 70-74. 48 Richter M, Cyranka U, Nowak G, Walsmann P. Pharmacokinetics of 125I-hirudin in rats and dogs. Folia Haematol 1988; 115: 64-69. 49 Tripier D. Hirudin: a family of iso-proteins, isolation and sequence determination of new hirudins. Folia Haematol 1988; 115: 30-35. 50 Vogel G, Markwardt F. Preliminary clinical reports on the antithrombotic action of hirudin (Abstr). Thromb Res (Suppl) 1987; 07: 42. 51 Vogel G, Markwardt F. Clinical use of hirudin. Folia Haematol 1988; 115: 113-18. 52 Walsmann P. Über den Einsatz des spezifischen Thrombininhibitors Hirudin für diagnostische und biochemische Untersuchungen. Pharmazie 1988; 43: 737-44. 53 Walsmann P, Kaiser B. Biochemical and pharmacological properties of recombinant hirudin. Drugs of Today 1989; 25: 473-85. 54 Walsmann P, Markwardt F. Biochemische und pharmakologische Aspekte des Thrombininhibitors Hirudin. Pharmazie 1981; 36: 653-60. 55 Walsmann P, Markwardt F. On the isolation of the thrombin inhibitor hirudin. Thromb Res 1985; 40: 563-70.
